GRAIL, Inc. (GRAL) stock
GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$105.88+0.28 (+0.27%)
Close on Nov 17, 2026Market cap $4.73BP/E –Yield –
Grail price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Grail's price to sales ratio was 34.0× on Nov 11, 2026, against 28.1× a year earlier. Over the last 2 years it ranged from 4.9× to 38.8×, with a median of 14.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 34.0× | +12.1 |
| 2025 | Dec 31, 2025 | 21.8× | +16.8 |
| 2024 | Dec 31, 2024 | 5.0× | – |
See a number that looks wrong?